Zobrazeno 101 - 110
of 153
pro vyhledávání: '"Melissa E. Hughes"'
Autor:
Michael A. Bookman, Jane C. Weeks, Michael J. Hassett, Joyce C. Niland, Robert W. Carlson, Stephen B. Edge, Richard L. Theriault, Melissa E. Hughes, Rebecca A. Ottesen
Publikováno v:
Medical Care. 46:762-770
Although many quality measures have been created, there is no consensus regarding which are the most important. We sought to develop a simple, explicit strategy for prioritizing breast cancer quality measures based on their potential to highlight are
Autor:
Douglas W. Blayney, Jane C. Weeks, Richard L. Theriault, Rebecca A. Ottesen, Y. Wong, Ann H. Partridge, Erica T. Warner, Melissa E. Hughes, Eric P. Winer, Joyce C. Niland, Rulla M. Tamimi, Stephen B. Edge
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(20)
Purpose To evaluate the relationship between race/ethnicity and breast cancer–specific survival according to subtype and explore mediating factors. Patients and Methods Participants were women presenting with stage I to III breast cancer between Ja
Autor:
Jane C. Weeks, Rebecca A. Ottesen, Richard L. Theriault, Stephen B. Edge, Joyce C. Niland, Melissa E. Hughes, Thomas A. Buchholz, Michael A. Bookman
Publikováno v:
Journal of Clinical Oncology. 24:361-369
Purpose Benchmark data regarding quality measures of breast cancer management are needed. We investigated rates of radiation use after breast conservation therapy (BCT) for patients treated for ductal carcinoma-in-situ (DCIS) or invasive breast cance
Autor:
Leigh Neumayer, Kala Visvanathan, Melissa E. Hughes, Keith Stockerl-Goldstein, Beverly Moy, Hope S. Rugo, Jane C. Weeks, Amanda L. Blackford, R. L. Theriault, Lori J. Goldstein, Judith E. Karp, Terry S. Langbaum, Antonio C. Wolff
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 33, iss 4
Purpose Outcomes for early-stage breast cancer have improved. First-generation adjuvant chemotherapy trials reported a 0.27% 8-year cumulative incidence of myelodysplastic syndrome/acute myelogenous leukemia. Incomplete ascertainment and follow-up ma
Autor:
Ines, Vaz-Luis, Melissa E, Hughes, Angel M, Cronin, Hope S, Rugo, Stephen B, Edge, Beverly, Moy, Richard L, Theriault, Michael J, Hassett, Eric P, Winer, Nancy U, Lin
Publikováno v:
Cancer. 121(12)
Among patients with stage I breast cancer, there is significant uncertainty concerning the optimal threshold at which to consider chemotherapy, and when considered, there is controversy regarding whether to consider non-intensive versus intensive reg
Autor:
Judith E. Karp, Antonio C. Wolff, Leigh Neumayer, Beverly Moy, TS Langbaum, HS Rugo, Lori J. Goldstein, Kala Visvanathan, Melissa E. Hughes, Amanda L. Blackford, Jane C. Weeks, Keith Stockerl-Goldstein
Publikováno v:
Cancer Research. 72:S3-5
BACKGROUND: Cooperative group trials and institutional series reported the risk of MDS and/or AML after adjuvant chemotherapy for early stage breast cancer (eg, NSABP 0.21%, Smith JCO 2003; ECOG 2197 0.5%, Goldstein ASCO 2012). We examined the incide
Autor:
J. Christopher Love, Gad Getz, Samuel S. Freeman, Melissa E. Hughes, Eric P. Winer, Greg Gydush, Nikhil Wagle, Daniel G. Stover, Sara M. Tolaney, Nan Lin, Gavin Ha, Viktor A. Adalsteinsson, Matthew Meyerson, Hao Guo, William T. Barry, Ian E. Krop, Sarah C. Reed, Denisse Rotem, Justin Rhoades, Heather A. Parsons
Publikováno v:
Journal of Clinical Oncology. 35:1092-1092
1092 Background: Triple-negative breast cancer (TNBC) is a poor prognosis breast cancer subset characterized by relatively few mutations but extensive copy number alterations (CNAs). Cell-free DNA (cfDNA) offers the potential to overcome infrequent t
Autor:
Massimo Cristofanilli, Melissa E. Hughes, Jennifer M. Matro, Yu-Ning Wong, Tianyu Li, Jane C. Weeks, Rebecca A. Ottesen
Background Inflammatory breast cancer (IBC) is an uncommon clinicopathologic entity characterized by rapid progression and aggressive behavior. We used the National Comprehensive Cancer Network (NCCN) Outcomes Database to characterize recurrence patt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c39d845cdc47cd796f8311d558b01ba
https://europepmc.org/articles/PMC4422394/
https://europepmc.org/articles/PMC4422394/
Autor:
Richard L. Theriault, Rebecca A. Ottesen, Ines Vaz-Luis, Nan Lin, Harold J. Burstein, Melissa E. Hughes, Hope S. Rugo, Eric P. Winer, Rizvan Mamet, Ana M. Gonzalez-Angulo, Jane C. Weeks, Stephen B. Edge, Beverly Moy
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 32, iss 20
Purpose Treatment decisions for patients with T1a,bN0M0 breast cancer are challenging. We studied the time trends in use of adjuvant chemotherapy and survival outcomes among these patients. Patients and Methods This was a prospective cohort study wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ebbafbb6779e2c62ecc50312885c1d
https://europepmc.org/articles/PMC4076026/
https://europepmc.org/articles/PMC4076026/
Autor:
Rinaa S. Punglia, Jane C. Weeks, Stephen B. Edge, Wei Jiang, Caprice C. Greenberg, Laurel A. Habel, Larissa Nekhlyudov, Melissa E. Hughes, Luana Acton, Ninah Achacoso, Deborah Schrag
The optimal treatment strategy for ductal carcinoma in situ (DCIS) continues to evolve and should consider the consequences of initial treatment on the likelihood, type, and treatment of recurrences.We conducted a retrospective cohort study using two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793cdeede75dc296aacb3eae1ea2b90c
https://europepmc.org/articles/PMC4539255/
https://europepmc.org/articles/PMC4539255/